Articles with "develop commercialize" as a keyword



Q218—public flotation jackpot

Sign Up to like & get
recommendations!
Published in 2018 at "Nature Biotechnology"

DOI: 10.1038/nbt.4249

Abstract: Sage Therapeutics Shionogi 90 Sage grants Shionogi exclusive rights in Japan, Taiwan and South Korea to SAGE-217, a next-generation GABAA positive allosteric small-molecule modulator to treat major depressive disorder Skyhawk Therapeutics Celgene 60 Skyhawk grants… read more here.

Keywords: exclusive rights; develop commercialize; q218 public; small molecule ... See more keywords